Eliana Miranda

1.7k total citations
70 papers, 1.1k citations indexed

About

Eliana Miranda is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Eliana Miranda has authored 70 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 16 papers in Genetics and 16 papers in Oncology. Recurrent topics in Eliana Miranda's work include Hematopoietic Stem Cell Transplantation (21 papers), Chronic Myeloid Leukemia Treatments (18 papers) and Chronic Lymphocytic Leukemia Research (14 papers). Eliana Miranda is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Chronic Myeloid Leukemia Treatments (18 papers) and Chronic Lymphocytic Leukemia Research (14 papers). Eliana Miranda collaborates with scholars based in Brazil, United States and Italy. Eliana Miranda's co-authors include Cármino Antônio De Souza, Afonso Celso Vigorito, Francisco Aranha, Raul C. Ribeiro, Bonald C. Figueiredo, Carlos Rodríguez‐Galindo, Rita Marques, Lílian Maria Cristófani, Mara Albonei Dudeque Pianovski and Luiz Drude de Lacerda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Eliana Miranda

67 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eliana Miranda Brazil	16	443	297	236	201	193	70	1.1k
William W.L. Choi United States	13	260 0.6×	256 0.9×	229 1.0×	109 0.5×	131 0.7×	18	1.1k
Zahid Kaleem United States	21	133 0.3×	270 0.9×	229 1.0×	117 0.6×	197 1.0×	49	1.3k
Kirsten van Lom Netherlands	25	579 1.3×	130 0.4×	427 1.8×	134 0.7×	253 1.3×	47	1.5k
Lesa Nelson United States	17	405 0.9×	303 1.0×	127 0.5×	75 0.4×	87 0.5×	31	1.3k
Souichi Suenobu Japan	15	291 0.7×	152 0.5×	95 0.4×	106 0.5×	122 0.6×	56	945
Renato Mastrangelo Italy	21	235 0.5×	160 0.5×	259 1.1×	238 1.2×	125 0.6×	57	1.2k
Juehua Gao United States	16	197 0.4×	67 0.2×	269 1.1×	68 0.3×	233 1.2×	60	1.1k
E Madon Italy	19	426 1.0×	126 0.4×	437 1.9×	85 0.4×	130 0.7×	74	1.4k
Ronald Reimer United States	20	139 0.3×	543 1.8×	166 0.7×	118 0.6×	57 0.3×	45	1.7k
Jiayun Lu United States	17	316 0.7×	107 0.4×	157 0.7×	229 1.1×	273 1.4×	53	1.5k

Countries citing papers authored by Eliana Miranda

Since Specialization

Citations

This map shows the geographic impact of Eliana Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eliana Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eliana Miranda more than expected).

Fields of papers citing papers by Eliana Miranda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eliana Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eliana Miranda. The network helps show where Eliana Miranda may publish in the future.

Co-authorship network of co-authors of Eliana Miranda

This figure shows the co-authorship network connecting the top 25 collaborators of Eliana Miranda. A scholar is included among the top collaborators of Eliana Miranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eliana Miranda. Eliana Miranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Palma, Leonardo Carvalho, et al.. (2023). Tyrosine Kinase Inhibitor Withdrawal Syndrome in Chronic Myeloid Leukemia Patients Participants of Two Discontinuation Clinical Trials. Blood. 142(Supplement 1). 6368–6368. 2 indexed citations

Miranda, Eliana, et al.. (2021). Association of an expanded inflammatory mediators response with clinical and laboratory data in the postoperative period of pulmonary resection: a prospective clinical study. Revista do Colégio Brasileiro de Cirurgiões. 48.

Miranda, Eliana, et al.. (2021). Efficacy of a hypolipid diet in patients with primary antiphospholipid syndrome with dyslipidemia: a prospective study. Journal of Thrombosis and Thrombolysis. 53(2). 390–398. 4 indexed citations

Costa, André Luiz Ferreira, Eliana Miranda, Afonso Celso Vigorito, et al.. (2020). Oral shedding of CMV and HSV‐1 in hematopoietic stem cell transplantation patients. Oral Diseases. 27(6). 1572–1579. 3 indexed citations

Mosci, Camila, Fernando Vieira Pericole, Gislaine Borba Oliveira, et al.. (2020). 99mTc-sestamibi SPECT/CT and 18F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma. Nuclear Medicine Communications. 41(10). 1081–1088. 9 indexed citations

Miranda, Eliana, et al.. (2019). Impact of Comorbidities on Survival of Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors. Blood. 134(Supplement_1). 2938–2938. 2 indexed citations

Castro, Rosane Silvestre de, et al.. (2018). Prevalence and Risk Factors of self-reported dry eye in Brazil using a short symptom questionnaire. Scientific Reports. 8(1). 2076–2076. 49 indexed citations

Pagnano, Kátia Bórgia Barbosa, Eliana Miranda, Márcia Torresan Delamain, et al.. (2017). Pilot Study of Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia with Deep Molecular Response (EDI-PIO) — Evaluation of Pioglitazone in Treatment-Free Remission. Blood. 130. 1595–1595. 1 indexed citations

Aranha, Francisco, Jeane Eliete Laguila Visentainer, Sandra Helena Alves Bonon, et al.. (2016). Synergistic effect of KIR ligands missing and cytomegalovirus reactivation in improving outcomes of haematopoietic stem cell transplantation from HLA-matched sibling donor for treatment of myeloid malignancies. Human Immunology. 77(10). 861–868. 9 indexed citations

10.

Pagnano, Kátia Bórgia Barbosa, Eliana Miranda, Márcia Torresan Delamain, et al.. (2013). Predictive Value Of Early Molecular Responses In Outcomes Of Patients With Chronic Myeloid Leukemia Treated With Imatinib In First-Line Therapy. Blood. 122(21). 4941–4941. 1 indexed citations

11.

Miranda, Eliana, et al.. (2012). Evaluation of respiratory conditions in early phase of hematopoietic stem cell transplantation. SHILAP Revista de lepidopterología. 34(3). 188–192. 11 indexed citations

12.

Miranda, Eliana, et al.. (2012). Functional evaluation indicates physical losses after hematopoietic stem cell transplantation. SHILAP Revista de lepidopterología. 34(5). 345–351. 15 indexed citations

13.

Vigorito, Afonso Celso, Luís Fernando Bouzas, Vaneuza Araújo Moreira Funke, et al.. (2011). A multicenter feasibility study of chronic graft-versus-host disease according to the National Institute of Health criteria. SHILAP Revista de lepidopterología. 33(4). 283–289. 5 indexed citations

14.

Miranda, Eliana, Márcio Nucci, Afonso Celso Vigorito, et al.. (2011). Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas. SHILAP Revista de lepidopterología. 33(6). 432–438. 2 indexed citations

15.

Tolley, Keith, et al.. (2010). Cost effectiveness of deferasirox compared to desferrioxamine in the treatment of iron overload in lower-risk, transfusion-dependent myelodysplastic syndrome patients. Journal of Medical Economics. 13(3). 559–570. 9 indexed citations

16.

Cunha, Anderson Ferreira da, Eliana Miranda, Roberto Zulli, et al.. (2009). New mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. Leukemia & lymphoma. 50(7). 1148–1154. 10 indexed citations

17.

Vigorito, Afonso Celso, Francisco Aranha, Eliana Miranda, et al.. (2009). Brazilian Experience Using High-Dose Sequential Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma. Clinical Lymphoma & Myeloma. 9(6). 449–454. 2 indexed citations

18.

Tsuneto, Luiza Tamie, Sofia Rocha Lieber, Afonso Celso Vigorito, et al.. (2007). Associação entre HLA e leucemia em uma população brasileira de etnia mista. Revista da Associação Médica Brasileira. 53(3). 252–256. 11 indexed citations

19.

Visentainer, Jeane Eliete Laguila, Sofia Rocha Lieber, Afonso Celso Vigorito, et al.. (2005). Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population. Cytokine. 32(3-4). 171–177. 37 indexed citations

20.

Souza, Cármino Antônio De, Afonso Celso Vigorito, Francisco Aranha, et al.. (2003). Immature reticulocytes as an early predictor of engraftment in autologous and allogeneic bone marrow transplantation. Clinical & Laboratory Haematology. 25(1). 47–54. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact